Search

Brian L. Cassidy

Examiner (ID: 19285, Phone: (571)270-7237 , Office: P/3618 )

Most Active Art Unit
3618
Art Unit(s)
3618
Total Applications
301
Issued Applications
235
Pending Applications
1
Abandoned Applications
64

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18474636 [patent_doc_number] => 20230208924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => INTRAVENOUS ADMINISTRATION OF SUPRAPHYSIOLOGIC PLATELET RICH PLASMA FOR NEUROLOGICAL DISORDERS [patent_app_type] => utility [patent_app_number] => 18/111439 [patent_app_country] => US [patent_app_date] => 2023-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8306 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18111439 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/111439
INTRAVENOUS ADMINISTRATION OF SUPRAPHYSIOLOGIC PLATELET RICH PLASMA FOR NEUROLOGICAL DISORDERS Feb 16, 2023 Pending
Array ( [id] => 18647909 [patent_doc_number] => 20230293688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => FUSOGENIC RHABDOVIRUS GLYCOPROTEINS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/167444 [patent_app_country] => US [patent_app_date] => 2023-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40729 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18167444 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/167444
FUSOGENIC RHABDOVIRUS GLYCOPROTEINS AND USES THEREOF Feb 9, 2023 Pending
Array ( [id] => 18647909 [patent_doc_number] => 20230293688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => FUSOGENIC RHABDOVIRUS GLYCOPROTEINS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/167444 [patent_app_country] => US [patent_app_date] => 2023-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40729 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18167444 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/167444
FUSOGENIC RHABDOVIRUS GLYCOPROTEINS AND USES THEREOF Feb 9, 2023 Pending
Array ( [id] => 18806908 [patent_doc_number] => 20230381241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => METHODS OF MANUFACTURE OF IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS [patent_app_type] => utility [patent_app_number] => 18/094148 [patent_app_country] => US [patent_app_date] => 2023-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22817 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18094148 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/094148
Methods of manufacture of immunocompatible chorionic membrane products Jan 5, 2023 Issued
Array ( [id] => 18628483 [patent_doc_number] => 20230287348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => METHOD FOR THE GENERATION OF GENETICALLY MODIFIED CELLS [patent_app_type] => utility [patent_app_number] => 18/147891 [patent_app_country] => US [patent_app_date] => 2022-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18147891 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/147891
METHOD FOR THE GENERATION OF GENETICALLY MODIFIED CELLS Dec 28, 2022 Pending
Array ( [id] => 18628483 [patent_doc_number] => 20230287348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => METHOD FOR THE GENERATION OF GENETICALLY MODIFIED CELLS [patent_app_type] => utility [patent_app_number] => 18/147891 [patent_app_country] => US [patent_app_date] => 2022-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18147891 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/147891
METHOD FOR THE GENERATION OF GENETICALLY MODIFIED CELLS Dec 28, 2022 Pending
Array ( [id] => 18334371 [patent_doc_number] => 20230126319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => Products Derived from Amniotic Fluid and Methods of Use [patent_app_type] => utility [patent_app_number] => 18/081136 [patent_app_country] => US [patent_app_date] => 2022-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -85 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18081136 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/081136
Products Derived from Amniotic Fluid and Methods of Use Dec 13, 2022 Pending
Array ( [id] => 18536049 [patent_doc_number] => 20230241136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => HISTAMINE-PRODUCING BACTERIAL STRAINS AND THEIR USE IN CANCER [patent_app_type] => utility [patent_app_number] => 18/060626 [patent_app_country] => US [patent_app_date] => 2022-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11942 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18060626 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/060626
HISTAMINE-PRODUCING BACTERIAL STRAINS AND THEIR USE IN CANCER Nov 30, 2022 Pending
Array ( [id] => 18536049 [patent_doc_number] => 20230241136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => HISTAMINE-PRODUCING BACTERIAL STRAINS AND THEIR USE IN CANCER [patent_app_type] => utility [patent_app_number] => 18/060626 [patent_app_country] => US [patent_app_date] => 2022-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11942 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18060626 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/060626
HISTAMINE-PRODUCING BACTERIAL STRAINS AND THEIR USE IN CANCER Nov 30, 2022 Pending
Array ( [id] => 18336987 [patent_doc_number] => 20230128936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => METHODS OF MANUFACTURE OF IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS [patent_app_type] => utility [patent_app_number] => 17/971980 [patent_app_country] => US [patent_app_date] => 2022-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25754 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17971980 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/971980
METHODS OF MANUFACTURE OF IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS Oct 23, 2022 Pending
Array ( [id] => 18309245 [patent_doc_number] => 20230113145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS [patent_app_type] => utility [patent_app_number] => 17/969461 [patent_app_country] => US [patent_app_date] => 2022-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22834 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969461 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/969461
IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS Oct 18, 2022 Pending
Array ( [id] => 18309245 [patent_doc_number] => 20230113145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS [patent_app_type] => utility [patent_app_number] => 17/969461 [patent_app_country] => US [patent_app_date] => 2022-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22834 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969461 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/969461
IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS Oct 18, 2022 Pending
Array ( [id] => 18309245 [patent_doc_number] => 20230113145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS [patent_app_type] => utility [patent_app_number] => 17/969461 [patent_app_country] => US [patent_app_date] => 2022-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22834 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969461 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/969461
IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS Oct 18, 2022 Pending
Array ( [id] => 18595354 [patent_doc_number] => 20230270142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => COMPOSITION CONTAINING EQUOL AND ORNITHINE [patent_app_type] => utility [patent_app_number] => 17/955898 [patent_app_country] => US [patent_app_date] => 2022-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5775 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17955898 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/955898
COMPOSITION CONTAINING EQUOL AND ORNITHINE Sep 28, 2022 Pending
Array ( [id] => 18595354 [patent_doc_number] => 20230270142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => COMPOSITION CONTAINING EQUOL AND ORNITHINE [patent_app_type] => utility [patent_app_number] => 17/955898 [patent_app_country] => US [patent_app_date] => 2022-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5775 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17955898 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/955898
COMPOSITION CONTAINING EQUOL AND ORNITHINE Sep 28, 2022 Pending
Array ( [id] => 18211093 [patent_doc_number] => 20230057356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => ENHANCEMENT OF UMBILICAL CORD MESENCHYMAL STEM CELL THERAPEUTIC ACTIVITY BY STIMULATORS OF T REGULATORY CELLS AND/OR CELLS EXPRESSING CD73 [patent_app_type] => utility [patent_app_number] => 17/820789 [patent_app_country] => US [patent_app_date] => 2022-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8826 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820789 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/820789
ENHANCEMENT OF UMBILICAL CORD MESENCHYMAL STEM CELL THERAPEUTIC ACTIVITY BY STIMULATORS OF T REGULATORY CELLS AND/OR CELLS EXPRESSING CD73 Aug 17, 2022 Abandoned
Array ( [id] => 18034516 [patent_doc_number] => 20220378731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => Composition For Treating Tauopathy In The Brain, Brain Stem and Spinal Column [patent_app_type] => utility [patent_app_number] => 17/884360 [patent_app_country] => US [patent_app_date] => 2022-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6881 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17884360 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/884360
Composition For Treating Tauopathy In The Brain, Brain Stem and Spinal Column Aug 8, 2022 Abandoned
Array ( [id] => 18109857 [patent_doc_number] => 20230002737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => Methods and Apparatuses for Patient-Derived Micro-Organospheres [patent_app_type] => utility [patent_app_number] => 17/874136 [patent_app_country] => US [patent_app_date] => 2022-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21773 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17874136 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/874136
Methods and Apparatuses for Patient-Derived Micro-Organospheres Jul 25, 2022 Pending
Array ( [id] => 18869171 [patent_doc_number] => 11856944 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Organ care solution for ex-vivo machine perfusion of donor lungs [patent_app_type] => utility [patent_app_number] => 17/869701 [patent_app_country] => US [patent_app_date] => 2022-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8828 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17869701 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/869701
Organ care solution for ex-vivo machine perfusion of donor lungs Jul 19, 2022 Issued
Array ( [id] => 19432848 [patent_doc_number] => 20240301346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => CELLULAR MICROCOMPARTMENTS COMPRISING CELLS OF WHICH THE GENOMIC INTEGRITY IS MAINTAINED AFTER AMPLIFICATION AND PREPARATION METHOD [patent_app_type] => utility [patent_app_number] => 18/270924 [patent_app_country] => US [patent_app_date] => 2022-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12707 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270924 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/270924
CELLULAR MICROCOMPARTMENTS COMPRISING CELLS OF WHICH THE GENOMIC INTEGRITY IS MAINTAINED AFTER AMPLIFICATION AND PREPARATION METHOD May 10, 2022 Pending
Menu